NACDS: One Step Closer in Curbing Prescription Drug Abuse, Protecting Patients

Published Online: Tuesday, July 29, 2014
Follow Pharmacy_Times:
PRESS RELEASE

July 29, 2014, Arlington, Va. – A bipartisan bill that calls for a collaborative, coordinated approach to curbing prescription drug abuse and safeguarding patients is headed to the U.S. House for a vote later today.

The Ensuring Patient Access and Effective Drug Enforcement Act of 2013 (H.R. 4709) would establish a congressionally-mandated report from the Department of Health and Human Services (HHS), to explore opportunities to better coordinate federal and stakeholder activities in addressing prescription drug abuse and diversion without compromising access to medications for patients who legitimately need them.

Sponsored by Rep. Tom Marino (R-PA), Energy and Commerce Committee Vice Chair Rep. Marsha Blackburn (R-TN), Rep. Peter Welch (D-VT) and Rep. Judy Chu (D-CA), and cosponsored by ten representatives, the bill’s designated HHS report would be facilitated in consultation with the Drug Enforcement Agency and Office of the National Drug Control Policy, and with input from specific stakeholders, including pharmacy.

NACDS has emphasized its support of this legislation since its introduction, urging lawmakers to pass the bill in the interest of patients.

“We applaud Reps. Marino and Blackburn for their leadership on this bipartisan bill, and commend the House for bringing the bill to a vote, said NACDS President and CEO Steven C. Anderson, IOM, CAE. “NACDS and chain pharmacy are committed to partnering with federal and state agencies, law enforcement personnel, policymakers, and other stakeholders to work on viable strategies to simultaneously advance patient health and prevent prescription drug abuse. Today’s vote is a step closer to achieving these goals.”

“Looking ahead, we urge the U.S. Senate to move swiftly in passing legislation that will achieve this vital goal," said Anderson.

Related Articles
Deaths related to oxycodone overdose dropped 25% in Florida after the state adopted a Prescription Drug Monitoring Program to track controlled substance dispensing.
The FDA has outlined the type of studies opioids need to complete to win approval for abuse-deterrence.
In response to a recent resurgence in fentanyl abuse, the DEA today issued a nationwide alert about the dangers of the drug, describing it as a threat to health and public safety.
AWARxE is a free resource created by the National Association of Boards of Pharmacy to raise awareness on the dangers of prescription drug abuse.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$